CymaBay Therapeutics, Inc.

Invesco Ltd.

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/13/2024

Shares

727,706

Value ($000)

17,188

Weight

0.0%

2020 Q1 - 2023 Q4 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/13/2024	17,188	0.0%	727,706	12/31/2023
2023 Q3	11/13/2023	14,042	0.0%	941,808	9/30/2023
2023 Q2	8/11/2023	10,096	0.0%	922,019	6/30/2023
2023 Q1	5/12/2023	8,324	0.0%	954,627	3/31/2023
2022 Q4	2/13/2023	872	0.0%	139,133	12/31/2022
2022 Q3	11/14/2022	590	0.0%	168,694	9/30/2022
2022 Q2	8/15/2022	664	0.0%	225,254	6/30/2022
2022 Q1	5/16/2022	692	0.0%	222,495	3/31/2022
2021 Q4	2/14/2022	883	0.0%	261,207	12/31/2021
2021 Q3	11/15/2021	944	0.0%	258,590	9/30/2021
2021 Q2	8/17/2021	1,038	0.0%	238,108	6/30/2021
2021 Q1	5/17/2021	1,021	0.0%	225,072	3/31/2021
2020 Q4	2/16/2021	1,242	0.0%	216,407	12/31/2020
2020 Q3	11/16/2020	13,594	0.0%	1,877,586	9/30/2020
2020 Q2	8/14/2020	334	0.0%	95,728	6/30/2020
2020 Q1	5/15/2020	156	0.0%	105,614	3/31/2020